ANNUAL SCIENTIFIC RETREAT
|
Network, Talk Science and Form New Collaborations
Thursday, July 9 from 4:30-8:30 pm in the Wolstein Research Building Auditorium and Atrium, CWRU Campus AND
Friday, July 10 from 7:45 am-7 pm at Corporate College East (4400 Richmond Rd, Warrensville Heights 44128)
Register: Click here
The Cancer Center Annual Scientific Retreat is an event that we look forward to all year. As one member recently put it, this is one of the few events where our entire Center gathers together in person to share great ideas. This statement pretty much sums up the sentiment of the retreat, and the reason why we hope all of you will make every effort to attend.
Highlights of this two-day event include:
- Keynote address by Dr. Crystal Mackall, Chief, Pediatric Oncology Branch at the National Cancer Institute, on immunotherapy trials. Dr. Mackall will also participate in Friday's events.
- Talks by Cancer Center members focusing on new areas of research and interaction within our Center including Immunotherapy, Cancer Disparities, Metabolism & Cancer, and Melanoma Research.
- Presentations by Cancer Center Pilot Award winners highlighting some of the freshest and most exciting projects.
- Poster presentations by students, postdocs and fellows - the next generation of cancer researchers.
- Chance to catch up with fellow researchers and hopefully form some new collaborations. We are pleased to have many new attendees registered this year.
Also, remember each Program will have a lunchtime breakout session. This is your chance to have your voice heard! During these meetings, your Program Leaders to review with you key elements about your program such as:
- Focusing the strategic plan on your program activities, initiatives and needs. As the Cancer Center develops initiatives, makes investments, and approves pilot grants, alignment with the strategic plan is critical.
- Pilot awards process. This year the program leaders will forward your requests, as they align with the program strategic plan, to Center leadership for approval. Each program will have funds to spend supporting your research, but you need to be engaged to benefit!!
- Discussion about how to relate our science - within your program- to our catchment area. This is a critical NCI grant review criteria and we need to brainstorm about the process. We have great examples but we need your help with the links all of you are already working on!
|
Be Part of the Movement to Raise Funds for Cancer Research
Excitement is building as we draw closer to the weekend of July 17-19 and the VeloSano bike ride. We are proud to be part of the event, and hope you will join us as a rider, volunteer, cheerleader, or fundraiser!
Last year VeloSano successfully completed its inaugural year, raising nearly $2 million that was directly awarded to cancer research. This year, funding will be distributed across all Case CCC institutions, with attention paid to fair distribution based on funds raised. All awardees must participate as riders, volunteers or organizers for the ride.
Want to know more about VeloSano and why people are participating? Talk to any of the riders and ask them- they would love to tell you why they support the ride and why it is important. In fact, the Case Daily recently sat down with Bill Schiemann, captain of the Schiemann subteam, to discuss VeloSano and why he is riding. Read what he had to say.
So how can you help? There is still time to join our team as a rider or virtual rider, or create your own subteam. We will help you train by offering advice and organizing practice rides.
Sign up to be a volunteer at our Cheer Station in the green space on Adelbert Road. Our cheer team will cheer on VeloSano riders by ringing cowbells, holding signs and making noise to keep everyone motivated. All volunteers will receive a t-shirt. Service hours will be awarded, so encourage your kids to join in the fun.
Finally, we need help with fundraising! Donate to our team or encourage others to donate. We are also selling 50/50 raffle tickets where the profit will support our team and riders. Tickets are $5 each or 5 for $20. Tickets can be purchased in the Cancer Center admin office at Wearn 152 or from Tracy Rehl on Wolstein 3. You may also email [email protected] to make purchase arrangements.
More information about VeloSano and our team is available on the Cancer Center website. You can also contact Team Captain Caroline El Sanadi ([email protected]) or Megan Kilbane ([email protected]).
|
5 questions with...cancer researcher, VeloSano rider Bill Schiemann Case Daily- Jun 26, 2015 Bill Schiemann, Co-Leader of the Breast Cancer Program at the Case Comprehensive Cancer Center and Professor in the Division of General Medical Sciences at CWRU, has devoted years to studying breast cancer-specifically, metastasis, or cancer's spread to other parts of the body, which is the cause of more than 90 percent of cancer deaths. Since joining Case Western Reserve University in 2009, Schiemann's lab has produced several breakthroughs in this area...
|
University Hospitals' proton therapy center nears completion with treatment system delivery Crain's Cleveland Business- Jun 26, 2015 The heart of University Hospitals' $30 million proton therapy center is expected to be delivered Saturday, June 27, marking a significant development in the long-awaited project that would pit the health system as the first in the state with the cancer-fighting technology...Traditional therapy systems can cost hundreds of millions of dollars and typically are the size of a football field, but the machine employed by UH - the Mevion S250 - requires less space and resources to operate, according to Dr. Nathan Levitan, president of UH Seidman Cancer Center and member of the Case Comprehensive Cancer Center. The accelerator itself weighs 15 tons, with the white tube housing it weighs an additional 40 tons.
|
Red5 Pharmaceuticals receives exclusive license to two technologies developed at Case Western Reserve University Crain's Cleveland Business- Jun 24, 2015
A Cleveland startup company called Red5 Pharmaceuticals has received an exclusive license to two technologies developed at Case Western Reserve University: a kit that can quickly determine whether a cancer patient will respond to a particular chemotherapy program, and an experimental cancer drug. The kit likely will be the company's first product. It's designed to tell oncologists whether patients with leukemia, lymphoma or solid tumors will respond to a particular treatment, within 24 hours. The KRun kit contains patented chemicals that are used to test samples from the patient...Red5's technology was developed by cofounder Anthony Berdis while he was an assistant professor of pharmacology at the university's medical school. Today, Berdis is chief scientific officer at Red5 and an assistant professor in the department of chemistry at Cleveland State University. Berdis is also a member of the Case Comprehensive Cancer Center. |
Researcher Discovers Metabolite of Prostate Cancer Drug More Effective at Treating Aggressive Tumors
Cleveland Clinic researchers have discovered for the first time that a metabolite of an FDA-approved drug for metastatic prostate cancer, abiraterone (Abi), has more anti-cancer properties than its precursor. The research was published online June 1 in Nature.
Nima Sharifi, MD, co-Leader of the Case Comprehensive Cancer Center GU Malignancies Program, found that abiraterone, a steroid inhibitor, is converted into the more physiologically active D4A (Δ4-abiraterone) in both patients and animal models with prostate cancer who take the drug. Furthermore, they found that D4A is more effective than abiraterone at killing aggressive prostate cancer cells, suggesting that some patients may benefit from direct treatment with D4A.
|
Pfizer 2015 ASPIRE Breast Cancer Research Awards Program Pfizer is pleased to announce the 2015 ASPIRE Breast Cancer Research Awards Program. The mission of this ASPIRE Awards program is to support clinical research of palbociclib in advanced breast cancer through a competitive grants program that advances knowledge of palbociclib in the treatment and disease management of ABC.
Deadline: September 8, 2015
|
National Institutes of Health - Transformative Research Award Program
The Transformative Research Award, run under the NIH Common Fund, was established to support exceptionally innovative, high-risk, and/or unconventional research projects that have the potential to create or overturn fundamental paradigms or otherwise have unusually broad impact. Such projects, due to their inherent risk, may be more difficult to support using a standard NIH R01 grant, but due to their potential impact, may merit pursuing. Little or no preliminary data are expected, but projects must clearly demonstrate the potential to produce a major impact in a broad area of biomedical or behavioral research.
LOI Deadline: September 9, 2015 Application Deadline: October 9, 2015
|
American Association for Cancer Research
The American Association for Cancer Research (AACR) is accepting applications for the following opportunities:
AACR Team Science Award
Nomination Deadline: August 5, 2015
Nomination Deadline: September 2, 2015
Nomination Deadline: September 9, 2015
Nomination Deadline: September 16, 2015
|
NIH BULLETIN - Notices and Funding Opportunities |
|
|
REGISTER TODAY!
Case CCC Annual Scientific Retreat
Jul 9-10, 2015
Details
|
Tues, Jun 30
Radiation Oncology Grand Rounds
Jill Barnholtz-Sloan, PhD
Associate Professor, Div. of General Medical Sciences-Oncology
CWRU
Brain Tumors: BIG science in a RARE disease
8:10 am Lerner 151
Translational Hematology & Oncology Research (THOR) Lecture Series
Britta Will, PhD Cell Biology
Albert Einstein College of Medicine, Bronx, NY
Transcriptional Dysregulation of Hematopoietic Stem Cell Fate Determination during Aging and Myeloid Transformation
1 pm R3-027 Cleveland Clinic
|
Mon, Jul 6
Tumor Immunology and Immunotherapy Focus Group meeting
4 pm Wearn 137
|
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
Case CCC Annual Scientific Retreat
Jul 9-10, 2015
Details
VeloSano
Jul 17-19, 2015
Details
Palliative Medicine and Supportive Oncology 2015
Jul 23-25, 2015
Marriott Key Center
Details
|
|
|
|